Illumina, Inc.
(NASDAQ : ILMN)

( )
ILMN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -5.23%207.410.0%$1713.99m
BIIBBiogen, Inc. 2.40%406.141.7%$1308.00m
SNSSSunesis Pharmaceuticals, Inc. 9.01%12.950.7%$905.25m
NVAXNovavax, Inc. -0.94%207.7179.8%$703.35m
AMGNAmgen, Inc. -0.65%241.191.3%$607.30m
BNTXBioNTech SE -7.53%220.580.0%$521.84m
GILDGilead Sciences, Inc. 0.13%68.151.0%$461.62m
VRTXVertex Pharmaceuticals, Inc. 0.92%194.801.9%$449.28m
ILMNIllumina, Inc. -0.23%452.143.5%$372.79m
REGNRegeneron Pharmaceuticals, Inc. 0.61%528.752.7%$364.34m
ALXNAlexion Pharmaceuticals, Inc. 0.00%181.652.0%$341.36m
OCGNOcugen, Inc. -3.31%6.130.0%$262.85m
EXASEXACT Sciences Corp. 2.56%125.0118.1%$192.21m
BNGOBionano Genomics, Inc. 3.17%7.820.0%$186.15m
ONTXOnconova Therapeutics, Inc. 6.93%7.561.8%$181.22m

Company Profile

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.